https://www.selleckchem.com/pr....oducts/orforglipron-
Copyright © 2020 Li, Wang, Li, Cheng, Zhang, Luo, Zhang, Gao, Lu and Li.[This corrects the article DOI 10.3389/fphar.2019.00511.]. Copyright © 2020 Trommer, Yeo, Persigehl, Bunck, Grüll, Schlaak, Theurich, von Bergwelt-Baildon, Morgenthaler, Herter, Celik, Marnitz and Baues.Background Myocardial infarction with non-obstructive coronary arteries (MINOCA) is a heterogeneous entity with relevant long-term major cardiovascular events. Several trials have demonstrated that dual antiplatelet therapy (DAPT), β-blocker, renin-ang
Like
Comment
Share
